APA (7th ed.) Citation

Villalona-Calero, M., Lam, E., Otterson, G., Zhao, J., Timmons, M., Subramaniam, D., . . . Bertino, E. (2012). 603 Phase II Trial of Oncolytic Reovirus in Combination with Chemotherapy in NSCLC Pts with Kras Activated Tumors. European Journal of Cancer, 48, 185. https://doi.org/10.1016/S0959-8049(12)72400-0

Chicago Style (17th ed.) Citation

Villalona-Calero, M., et al. "603 Phase II Trial of Oncolytic Reovirus in Combination with Chemotherapy in NSCLC Pts with Kras Activated Tumors." European Journal of Cancer 48 (2012): 185. https://doi.org/10.1016/S0959-8049(12)72400-0.

MLA (9th ed.) Citation

Villalona-Calero, M., et al. "603 Phase II Trial of Oncolytic Reovirus in Combination with Chemotherapy in NSCLC Pts with Kras Activated Tumors." European Journal of Cancer, vol. 48, 2012, p. 185, https://doi.org/10.1016/S0959-8049(12)72400-0.